Effects and mechanisms of phosphodiesterase type 5 inhibitors on rats with overactive bladder

National Medical Journal of China

Volumn 91, Issue 28, 2011, Pages 2001-2005

  Chen, Hong De ^a   Ye, Xue Ting ^a   Weng, Zhi Liang ^a   Li, Cheng Di ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Bladder detrusor muscle; Phosphoric diester hydrolases; Rats, inbred SHR; Rho kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CYCLIC GMP; RHO KINASE; VARDENAFIL; PHOSPHODIESTERASE V INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CAPACITY; BLADDER CONTRACTION; CONTROLLED STUDY; DETRUSOR MUSCLE; MALE; MICTURITION; MUSCLE RELAXATION; NONHUMAN; OVERACTIVE BLADDER; RAT; SIGNAL TRANSDUCTION; URODYNAMICS; ANIMAL; BLADDER; DRUG EFFECT; METABOLISM; SPONTANEOUSLY HYPERTENSIVE RAT; SPRAGUE DAWLEY RAT;

ANIMALS; MALE; PHOSPHODIESTERASE 5 INHIBITORS; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URODYNAMICS;

EID: 84870421969     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2011.28.016     Document Type: Article

References (10)

1. Broderick GA, Brock GB, Roehrborn CG, et al. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction. Urology, 2010, 75: 1452-1458.
2. Uckert S, Kuthe A, Jonas U, et al. Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. J Urol, 2001, 166: 2484-2490.
3. Takahashi R, Nishimura J, Hirano K, et al. Ca2 + sensitization in contraction of human bladder smooth muscle. J Urol, 2004, 172: 748-752.
4. McMurray G, Casey JH, Naylor AM. Animal models in urological disease and sexual dysfunction. Br J Pharmacol, 2006, 147: S62-S79.
5. Sakurada S, Okamoto H, Takuwa N, et al. Rho activation in excitatory agonist-stimulated vascular smooth muscle. Am J Physiol Cell physiol, 2001, 281: C571-C578.
6. Shiga N, Hirano K, Hirano M, et al. Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery. Circ Res, 2005, 96: 1014-1021.
7. Morelli A, Vignozzi L, Filippi S, et al. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder. Prostate, 2007, 67: 234-247.
8. Takahashi R, Nishimura J, Hirano K, et al. Ca2 + sensitization in contraction of human bladder smooth muscle. J Urol, 2004, 172: 748-752.
9. Rajasekaran M, Mehta N, Baquir A, et al. Rho-kinase inhibition suppresses potassium chloride-induced bladder hyperactivity in a rat model. Urology, 2007, 69: 791-794.
10. Loirand G, Guilluy C, Pacaud P. Regulation of Rho proteins by phosphorylation in the cardiovascular system. Trends Cardiovasc Med, 2006, 16: 199-204.